{"title":"Biologics Medications","description":"Discover the power of Biologics Medications, designed to revolutionize chronic condition management. These advanced therapies target specific pathways, providing effective relief for autoimmune disorders, cancer, and more. Enhance your health journey with cutting-edge treatments that prioritize precision and innovation. Explore biologics today, where science meets wellness, for optimal patient outcomes and improved quality of life.","products":[{"product_id":"herceptin-hylecta-trastuzumab-and-hyaluronidase-oysk-5-ml-rx","title":"Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL (RX) **Refrigeration Required","description":"\u003cp\u003eExperience effective breast cancer treatment with Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL), enhancing patient care.\u003c\/p\u003e\n\u003cp\u003eHerceptin Hylecta is a prescription medication used to treat certain types of breast cancer that are HER2-positive. It contains two active ingredients, trastuzumab and Hyaluronidase-Oysk, which work together to block the activity of HER2 proteins, slowing the growth and spread of cancer cells. The medication is administered as an injection under the skin every 3 weeks and the 5 mL refers to the amount of solution in each individual dose.\u003c\/p\u003e\n\u003cp\u003eHerceptin Hylecta is a medication for the treatment of certain types of breast cancer. It is a combination of the drug trastuzumab and the enzyme hyaluronidase. \u003cbr\u003e\u003cbr\u003eTrastuzumab is a monoclonal antibody that works by binding to a protein called HER2, which is present in large amounts in some breast cancer cells. By binding to HER2, trastuzumab can slow down or stop the growth and spread of these cancer cells.\u003cbr\u003e\u003cbr\u003eHyaluronidase is an enzyme that helps to break down a substance called hyaluronic acid, which is found in the connective tissues in the body. Hyaluronidase helps to create channels in these tissues, allowing medications like trastuzumab to be more easily absorbed into the bloodstream.\u003cbr\u003e\u003cbr\u003eTogether, trastuzumab and hyaluronidase work to fight against HER2-positive breast cancer by slowing down tumor growth and potentially shrinking it.\u003cbr\u003e\u003cbr\u003eHerceptin Hylecta is administered as an injection under the skin every 3 weeks. It may be used alone or in combination with other cancer treatments, such as chemotherapy or radiation therapy.\u003c\/p\u003e","brand":"Genentech USA","offers":[{"title":"Default Title","offer_id":40143942516808,"sku":"50242-0077-01","price":6495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Herceptin-Hylecta-_trastuzumab-and-Hyaluronidase-Oysk-Injection-5-mL.jpg?v=1710763216"},{"product_id":"herceptin-trastuzumab-injection-150-mg-cancer-treatment-medicine-rx-refrigeration-required","title":"Herceptin Trastuzumab Injection 150 mg (RX) * Refrigeration Required *","description":"\u003cp\u003eHerceptin Trastuzumab Injection 150 mg is a type of biologic cancer treatment medicine that is used to treat certain types of breast cancer, stomach cancer, and esophageal cancer. It contains the active ingredient trastuzumab, which works by targeting and blocking a protein called HER2 on the surface of cancer cells. This protein helps these cells grow and divide, and by blocking it, Herceptin can slow or stop the growth of cancer cells.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cem\u003e\u003cstrong\u003eThis item is Special Order.                                                                                                        -  Ships in 2-3 Business Days, Next Day Air, Signature Required.                                          -  Order cannot be cancelled once placed.\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eHerceptin Trastuzumab Injection 150 mg is a cancer treatment medicine that works by targeting and blocking the activity of a specific protein called HER2. This protein is found in high levels on the surface of some cancer cells, particularly in breast and stomach cancers.\u003cbr\u003e\u003cbr\u003eBy blocking HER2, Herceptin Trastuzumab reduces the growth and spread of cancer cells. It does this by slowing down the division of cancer cells, killing them, or stopping them from multiplying and spreading to other parts of the body.\u003cbr\u003e\u003cbr\u003eHerceptin Trastuzumab is typically used in combination with other cancer treatments, such as chemotherapy and radiation therapy. It may also be used alone for certain types of cancer.\u003cbr\u003e\u003cbr\u003eOverall, Herceptin Trastuzumab helps to slow down the progression of cancer and improve outcomes for patients with HER2-positive cancers.\u003c\/p\u003e","brand":"Genentech USA","offers":[{"title":"Default Title","offer_id":40143942647880,"sku":"50242-0132-01","price":2385.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Herceptin-Trastuzumab-Injection-150-mg-Vial.jpg?v=1710764147"},{"product_id":"ogivri-trastuzumab-injection-150-mg","title":"Ogivri Trastuzumab-Dkst Injection 150 mg **Refrigeration Required** (RX)","description":"\u003cp\u003eOgivri Trastuzumab-Dkst Injection 150 mg is a medication used in the treatment of certain types of breast cancer and stomach cancer. It contains the active ingredient trastuzumab and belongs to a class of drugs known as monoclonal antibodies. It works by specifically targeting and blocking the action of a protein called HER2, which is overexpressed in some types of cancer cells. By blocking HER2, Ogivri helps to slow down or stop the growth and spread of cancer cells.\u003c\/p\u003e\n\u003cp\u003eOgivri Trastuzumab-Dkst Injection 150 mg is a type of cancer medication called a monoclonal antibody. It targets a protein called human epidermal growth factor receptor 2 (HER2) which is found on the surface of some cancer cells. By binding to HER2, Ogivri helps to slow down or stop the growth and spread of HER2-positive cancer cells.\u003cbr\u003e\u003cbr\u003eSpecifically, Ogivri works by blocking the action of HER2, which is involved in stimulating cell growth and division. This helps to slow down the growth of cancer cells and can potentially lead to their death. In addition, Ogivri also stimulates an immune response against the cancer cells, further aiding in their destruction.\u003cbr\u003e\u003cbr\u003eOverall, by targeting HER2 and stimulating the immune system, Ogivri can help to treat certain types of breast and stomach cancers that overexpress this protein.\u003c\/p\u003e","brand":"Biocon Biologics","offers":[{"title":"Default Title","offer_id":40143946973256,"sku":"83257-0001-11","price":1295.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ogivri-Trastuzumab-Dkst-Injection-150-mg-Vial.jpg?v=1710765239"},{"product_id":"ontruzant-trastuzumab-dttb-injection-150-mg-cancer-medicine-refrigeration-required-rxrx","title":"Ontruzant Trastuzumab-Dttb Injection 150 mg Cancer Medicine **Refrigeration Required** (RX)","description":"\u003cp\u003eOntruzant Trastuzumab-Dttb Injection 150 mg is a cancer medication used to treat certain types of breast, stomach, and gastroesophageal junction cancers that overexpress the HER2 protein. This injection contains the active ingredient trastuzumab-dttb and belongs to a class of drugs known as monoclonal antibodies. It works by binding to the HER2 protein on cancer cells and blocking their growth and division, ultimately leading to cell death. Ontruzant is biosimilar to the brand-name medication Herceptin, meaning it has been shown to be highly similar in effectiveness and safety profile. It is administered intravenously (into a vein) by a healthcare provider.\u003c\/p\u003e\n\u003cp\u003eOntruzant Trastuzumab-Dttb belongs to a class of medications known as monoclonal antibodies. It works by binding to a specific protein called HER2 (human epidermal growth factor receptor 2). HER2 is found in high levels on the surface of some cancer cells, including breast and gastric cancers. This protein helps cancer cells grow and spread.\u003cbr\u003e\u003cbr\u003eBy blocking the function of HER2, Ontruzant Trastuzumab-Dttb slows down the growth and spread of cancer cells. It also stimulates the body's immune system to attack and destroy the cancer cells.\u003cbr\u003e\u003cbr\u003eIn addition, Ontruzant Trastuzumab-Dttb may work with other chemotherapy medications to further inhibit the growth of cancer cells.\u003cbr\u003e\u003cbr\u003eOverall, Ontruzant Trastuzumab-Dttb helps in treating cancers that overexpress HER2 protein, such as breast and gastric cancers.\u003c\/p\u003e","brand":"Organon Biosimilar","offers":[{"title":"Default Title","offer_id":40143947202632,"sku":"78206-0147-01","price":1795.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ontruzant--78206-0147-01-Trastuzumab-Dttb-Injection.jpg?v=1710767106"},{"product_id":"ontruzant-trastuzumab-dttb-injection-420-mg-cancer-medicine-refrigeration-required-rx","title":"Ontruzant Trastuzumab-Dttb Injection 420 mg **Refrigeration Required** (RX)","description":"\u003cp\u003eOntruzant Trastuzumab-Dttb Injection 420 mg is a cancer medicine used to treat breast cancer, stomach cancer, and other types of cancer that overexpress the HER2 protein. It belongs to a class of drugs called monoclonal antibodies, which work by targeting and inhibiting the activity of HER2 receptors on cancer cells. By blocking these receptors, Ontruzant helps to slow or stop the growth and spread of cancer cells in the body. This medication is administered through injection by a healthcare professional.\u003c\/p\u003e\n\u003cp\u003eOntruzant Trastuzumab-Dttb is a monoclonal antibody that works by binding to a protein called HER2, which is found on the surface of some cancer cells. When this antibody binds to HER2, it blocks the growth and spread of cancer cells. This helps to slow down or stop the growth of cancer and can also help the body's immune system to recognize and attack cancer cells. It is commonly used to treat breast cancer that overexpresses the HER2 protein.\u003c\/p\u003e\n\u003cp\u003eBrand: Organon Biosimilar\u003cbr\u003eStrength: 420 mg\u003cbr\u003eNDC: 78206-0148-01\u003cbr\u003eType: Powder Vial\u003c\/p\u003e","brand":"Organon Biosimilar","offers":[{"title":"Default Title","offer_id":40143947464776,"sku":"78206-0148-01","price":5150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ontruzant-Trastuzumab-Dttb-Injection-420-mg-Cancer-Medicine.jpg?v=1710767571"},{"product_id":"tyenne-tocilizumab-aazg-injection-200-10-ml-20-mg-ml-single-dose-vial-preservative-free-10-ml","title":"Tyenne Tocilizumab-Aazg Injection 200\/10 mL (20 mg\/mL) Single-Dose Vial, Preservative Free 10 mL (RX)","description":"\u003ch3\u003e\u003cstrong\u003eTop-Performing Biologic Treatment for Rheumatoid Arthritis \u0026amp; Autoimmune Diseases\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003eExperience advanced relief from chronic inflammation and joint pain with Tyenne Tocilizumab-Aazg, a \u003cstrong\u003ebiosimilar to Actemra\u003c\/strong\u003e and an industry-leading injectable biologic for autoimmune and inflammatory disorders. Manufactured by \u003cstrong\u003eFresenius Kabi\u003c\/strong\u003e, this preservative-free, single-dose vial offers a powerful solution for adults suffering from moderately to severely active \u003cstrong\u003erheumatoid arthritis (RA)\u003c\/strong\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eWhat is Tyenne Tocilizumab-Aazg Used For?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eTyenne (tocilizumab-aazg) belongs to a class of \u003cstrong\u003einterleukin-6 (IL-6) receptor antagonists\u003c\/strong\u003e and is FDA-approved for the treatment of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModerate to Severe Rheumatoid Arthritis (RA):\u003c\/strong\u003e For adults with inadequate response to one or more \u003cstrong\u003eDisease Modifying Anti-Rheumatic Drugs (DMARDs)\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAutoimmune \u0026amp; Inflammatory Diseases:\u003c\/strong\u003e Targeted therapy for unresponsive or complex autoimmune conditions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eWho Needs Tyenne Tocilizumab-Aazg?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults\u003c\/strong\u003e diagnosed with moderate to severe \u003cstrong\u003erheumatoid arthritis\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003ePatients who have not achieved sufficient relief with traditional DMARDs (\u003cstrong\u003eMethotrexate\u003c\/strong\u003e, \u003cstrong\u003eSulfasalazine\u003c\/strong\u003e)\u003c\/li\u003e\n\u003cli\u003eIndividuals requiring advanced \u003cstrong\u003eimmunosuppressive biologic therapy\u003c\/strong\u003e for chronic joint pain, swelling, and autoimmune inflammation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eKey Features \u0026amp; Health Benefits\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eBiosimilar to Actemra – Clinically Proven Efficacy\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eReduces Inflammation, Joint Pain, Stiffness \u0026amp; Swelling\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSlows Disease Progression \u0026amp; Joint Damage\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSingle-Dose, Preservative-Free Vial for Safety \u0026amp; Convenience\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHigh-Quality Manufacturing by Fresenius Kabi\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eDosing \u0026amp; Administration\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStandard Dose:\u003c\/strong\u003e 162 mg subcutaneous injection \u003cstrong\u003eonce every week\u003c\/strong\u003e with a tapering course of glucocorticoids.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAlternate Dose:\u003c\/strong\u003e 162 mg every other week may be considered by your healthcare provider.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonotherapy:\u003c\/strong\u003e Tyenne can be continued alone following discontinuation of glucocorticoids.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eHealth Category\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eBiologic Drugs for Autoimmune Disease\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRheumatoid Arthritis Treatments\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eImmunomodulatory \u0026amp; Anti-Inflammatory Medications\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003e\u003cstrong\u003eNDC:\u003c\/strong\u003e 65219-0592-10 \u003cstrong\u003eUPC:\u003c\/strong\u003e 365219592105\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eRelated RX Products\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eActemra (tocilizumab)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHumira (adalimumab)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEnbrel (etanercept)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOrencia (abatacept)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSimponi (golimumab)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMethotrexate (oral\/injectable)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eXeljanz (tofacitinib)\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003ePossible Side Effects\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eInjection site reactions (redness, pain, swelling, itching)\u003c\/li\u003e\n\u003cli\u003eUpper respiratory infections (sinus, throat)\u003c\/li\u003e\n\u003cli\u003eHeadache\u003c\/li\u003e\n\u003cli\u003eHigh blood pressure (hypertension)\u003c\/li\u003e\n\u003cli\u003eIncreased liver enzymes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eSerious Risks:\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eSerious infections due to reduced immune response\u003c\/li\u003e\n\u003cli\u003eIncreased cholesterol levels\u003c\/li\u003e\n\u003cli\u003eLiver dysfunction\u003c\/li\u003e\n\u003cli\u003eAllergic reactions (rash, swelling, trouble breathing)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSeek emergency medical attention for any severe or unusual symptoms.\u003c\/strong\u003e Always discuss benefits, risks, and monitoring requirements with your healthcare provider before starting Tyenne.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eOrder Tyenne Tocilizumab-Aazg for Advanced Arthritis Relief\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eRegain control of your health and manage rheumatoid arthritis effectively with \u003cstrong\u003eTyenne Tocilizumab-Aazg Injection\u003c\/strong\u003e—the trusted and clinically proven biosimilar for lasting inflammation and pain relief. \u003cstrong\u003eOrder online today\u003c\/strong\u003e or consult your healthcare professional about Tyenne from Fresenius Kabi.\u003c\/p\u003e","brand":"Fresenius Kabi Biosimilar","offers":[{"title":"Default Title","offer_id":53200194863472,"sku":"65219-0592-10","price":1369.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tyenne-Tocilizumab-Aazg-Injection-200-10-mL.jpg?v=1769175394"},{"product_id":"avtozma-tocilizumab-anoh-injection-80-mg-4-ml-20-mg-ml-single-dose-vial","title":"Avtozma (Tocilizumab-anoh) Injection 80 mg\/4 mL (20 mg\/mL) Single-dose Vial **Cold Ship (RX)","description":"\u003ch4\u003e\u003cstrong\u003eTop-Rated Biosimilar for Rheumatoid Arthritis \u0026amp; Autoimmune Disease Relief\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003eUnlock advanced therapy for inflammatory and autoimmune disorders with \u003cstrong\u003eAvtozma (tocilizumab-anoh)\u003c\/strong\u003e, an FDA-approved biosimilar to Actemra. This high-efficacy, preservative-free injectable from Celltrion USA delivers targeted management of moderate to severe rheumatoid arthritis, bringing renewed mobility, pain reduction, and joint protection to adults when traditional DMARDs are ineffective.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eWhat is Avtozma (Tocilizumab-anoh) Used For?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAvtozma\u003c\/strong\u003e is a powerful \u003cstrong\u003einterleukin-6 (IL-6) receptor antagonist\u003c\/strong\u003e used in the treatment of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRheumatoid Arthritis (RA):\u003c\/strong\u003e Reduces inflammation, joint pain, and swelling for adults with moderate to severe RA who have had inadequate response to DMARDs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAutoimmune and Inflammatory Disorders:\u003c\/strong\u003e Controls excessive immune response and inflammation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmunosuppressive Therapy:\u003c\/strong\u003e Used for certain conditions based on clinical judgment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eWho Needs Avtozma?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults with moderate to severe rheumatoid arthritis\u003c\/strong\u003e unresponsive to conventional therapies.\u003c\/li\u003e\n\u003cli\u003ePatients requiring a \u003cstrong\u003ebiologic DMARD, immune system modulator, or advanced anti-inflammatory injection\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eIndividuals seeking relief from \u003cstrong\u003echronic joint pain, swelling, and inflammation\u003c\/strong\u003e due to autoimmune disorders.\u003c\/li\u003e\n\u003cli\u003eHealthcare providers looking for a \u003cstrong\u003etrusted Actemra biosimilar\u003c\/strong\u003e alternative for their patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eHealth Category\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAutoimmune Disease Management\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRheumatoid Arthritis Treatment\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBiologic DMARDs\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eImmunosuppressive Medications\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBiologic Injection Therapy\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eKey Features \u0026amp; Benefits\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA-Approved Biosimilar to Actemra:\u003c\/strong\u003e Same clinical efficacy and safety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePowerful Inflammation Relief:\u003c\/strong\u003e Controls flares and reduces joint damage.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRapid Symptom Improvement:\u003c\/strong\u003e Effective for pain, swelling, and stiffness.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle-Dose, Preservative-Free Vial:\u003c\/strong\u003e Ensures safety and dosing accuracy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProduced by Celltrion USA:\u003c\/strong\u003e Renowned global biosimilar manufacturer.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eDosing \u0026amp; Administration\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAvtozma (tocilizumab-anoh) 80 mg\/4 mL\u003c\/strong\u003e (20mg\/mL) Single-Dose Vial\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cem\u003eAdministered as a subcutaneous (under the skin) injection.\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003eDosage and frequency are determined by healthcare providers based on clinical needs and patient factors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eRelated RX Biologics\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eActemra (tocilizumab)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTyenne (tocilizumab-aazg)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHumira (adalimumab)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEnbrel (etanercept)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSimponi (golimumab)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOrencia (abatacept)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMethotrexate (oral\/injection)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eXeljanz (tofacitinib)\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eSide Effects of Avtozma (Tocilizumab-anoh)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eMost Common Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eInjection site reactions (pain, redness, swelling)\u003c\/li\u003e\n\u003cli\u003eUpper respiratory tract infections (sinus, throat)\u003c\/li\u003e\n\u003cli\u003eHeadache\u003c\/li\u003e\n\u003cli\u003eHigh blood pressure (hypertension)\u003c\/li\u003e\n\u003cli\u003eIncreased liver enzymes\u003c\/li\u003e\n\u003cli\u003eGastrointestinal discomfort\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious Risks:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSevere infections (due to immune suppression)\u003c\/li\u003e\n\u003cli\u003eElevated cholesterol\u003c\/li\u003e\n\u003cli\u003eLiver dysfunction, abnormal liver tests\u003c\/li\u003e\n\u003cli\u003eAllergic reactions (hives, difficulty breathing, swelling)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eAlways consult your healthcare provider regarding risks, routine lab monitoring, and the management of any side effects. Seek emergency medical attention for signs of severe reaction.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eOrder Avtozma for Superior Rheumatoid Arthritis Relief\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eReclaim mobility and stop autoimmune joint damage with Avtozma (Tocilizumab-anoh)!\u003c\/strong\u003e Leverage the safety, efficacy, and savings of this advanced Actemra biosimilar—trusted by clinicians and patients across the USA. \u003cstrong\u003eFast shipping available. RX required. Contact your account specialist for reimbursement and insurance coverage information.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Celltrion USA Biosimilar","offers":[{"title":"Default Title","offer_id":53200515268976,"sku":"72606-0042-01","price":599.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Avtozma-Tocilizumab-anoh-Injection-80-mg-4-mL-Celltrion-72606-0042-01.jpg?v=1769185227"}],"url":"https:\/\/www.mountainside-medical.com\/collections\/biologics-medications.oembed?constraint=herceptin-hylecta","provider":"Mountainside Medical","version":"1.0","type":"link"}